TGFBR2 KO CB NK-Cells therapy (M.D. Anderson Cancer Center)

N/A

Report date: 2026/04/29 20:02:18

Base Information

Drug NameTGFBR2 KO CB NK-Cells therapy (M.D. Anderson Cancer Center)
Drug Alias NameTGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells therapy (M.D. Anderson Cancer Center)TRICK-NK - TROP2-targeted, Reprogrammed with IL-15, CBderived, Knockout (TGFBR2) NK cells therapy (M.D. Anderson Cancer Center)TRICK-NK
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy
Mechanisms of ActionNatural killer cell replacementsTumor-associated calcium signal transducer 2 modulators
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A